scholarly journals Influence of false-positive mammography results on subsequent screening: do physician recommendations buffer negative effects?

2012 ◽  
Vol 19 (1) ◽  
pp. 35-41 ◽  
Author(s):  
Jessica T DeFrank ◽  
Barbara K Rimer ◽  
J Michael Bowling ◽  
Jo Anne Earp ◽  
Erica S Breslau ◽  
...  

Objective Cancer screening guidelines often include discussion about the unintended negative consequences of routine screening. This prospective study examined effects of false-positive mammography results on women's adherence to subsequent breast cancer screening and psychological well-being. We also assessed whether barriers to screening exacerbated the effects of false-positive results. Methods We conducted secondary analyses of data from telephone interviews and medical claims records for 2406 insured women. The primary outcome was adherence to screening guidelines, defined as adherent (10–14 months), delayed (15–34 months), or no subsequent mammogram on record. Results About 8% of women reported that their most recent screening mammograms produced false-positive results. In the absence of self-reported advice from their physicians to be screened, women were more likely to have no subsequent mammograms on record if they received false-positive results than if they received normal results (18% vs. 7%, OR = 3.17, 95% CI = 1.30, 7.70). Receipt of false-positive results was not associated with this outcome for women who said their physicians had advised regular screening in the past year (7% vs. 10%, OR = 0.74, 95% CI = 0.38, 1.45). False-positive results were associated with greater breast cancer worry ( P < .01), thinking more about the benefits of screening ( P < .001), and belief that abnormal test results do not mean women have cancer ( P < .01), regardless of physicians' screening recommendations. Conclusion False-positive mammography results, coupled with reports that women's physicians did not advise regular screening, could lead to non-adherence to future screening. Abnormal mammograms that do not result in cancer diagnoses are opportunities for physicians to stress the importance of regular screening.

Cancer ◽  
2013 ◽  
Vol 119 (22) ◽  
pp. 3952-3958 ◽  
Author(s):  
Marta Roman ◽  
Rebecca A. Hubbard ◽  
Sofie Sebuodegard ◽  
Diana L. Miglioretti ◽  
Xavier Castells ◽  
...  

2011 ◽  
Vol 53 (1-2) ◽  
pp. 76-81 ◽  
Author(s):  
Dolores Salas ◽  
Josefa Ibáñez ◽  
Rubén Román ◽  
Dolores Cuevas ◽  
Maria Sala ◽  
...  

Cancers ◽  
2021 ◽  
Vol 13 (13) ◽  
pp. 3360
Author(s):  
Nadine Zielonke ◽  
Amarens Geuzinge ◽  
Eveline Heijnsdijk ◽  
Sirpa Heinävaara ◽  
Carlo Senore ◽  
...  

The main benefit of breast cancer (BC) screening is a reduction in mortality from BC. However, screening also causes harms such as overdiagnosis and false-positive results. The balance between benefits and harms varies by age. This study aims to assess how harm-to-benefit ratios of BC screening vary by age in the Netherlands, Finland, Italy and Slovenia. Using microsimulation models, we simulated biennial screening with 100% attendance at varying ages for cohorts of women followed over a lifetime. The number of overdiagnoses, false-positive diagnoses, BC deaths averted and life-years gained (LYG) were calculated per 1000 women. We compared four strategies (50–69, 45–69, 45–74 and 50–74) by calculating four harm-to-benefit ratios, respectively. Screening women at 45–74 or 50–74 years would be less beneficial in any of the four countries than screening women at 45–69, which would result in relatively fewer overdiagnoses per death averted or LYG compared to the reference strategy of 50–69. At the same time, false-positive results per death averted would increase substantially. Adapting the age range of BC screening is an option to improve harm-to-benefit ratios in all four countries. Prioritization of considered harms and benefits affects the interpretation of results.


2011 ◽  
Vol 22 (2) ◽  
pp. 331-340 ◽  
Author(s):  
Nieves Ascunce ◽  
◽  
María Ederra ◽  
Josu Delfrade ◽  
Araceli Baroja ◽  
...  

2011 ◽  
Vol 21 (10) ◽  
pp. 2083-2090 ◽  
Author(s):  
Raquel Zubizarreta Alberdi ◽  
◽  
Ana B. Fernández Llanes ◽  
Raquel Almazán Ortega ◽  
Rubén Roman Expósito ◽  
...  

2011 ◽  
Vol 22 (3) ◽  
pp. 404-408 ◽  
Author(s):  
D. Alamo-Junquera ◽  
C. Murta-Nascimento ◽  
F. Macia ◽  
M. Bare ◽  
J. Galceran ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Lorena Squillace ◽  
Lorenzo Pizzi ◽  
Flavia Rallo ◽  
Carmen Bazzani ◽  
Gianni Saguatti ◽  
...  

AbstractWe conducted a cross-sectional study to assess the likelihood of returning for routine breast cancer screening among women who have experienced a false-positive result (FPR) and to describe the possible individual and organizational factors that could influence subsequent attendance to the screening program. Several information were collected on demographic and clinical characteristics data. Electronic data from 2014 to 2016 related to breast screening program of the Local Health Authority (LHA) of Bologna (Italy) of women between 45 and 74 years old were reviewed. A total of 4847 women experienced an FPR during mammographic screening and were recalled to subsequent round; 80.2% adhered to the screening. Mean age was 54.2 ± 8.4 years old. Women resulted to be less likely to adhere to screening if they were not-Italian (p = 0.001), if they lived in the Bologna district (p < 0.001), if they had to wait more than 5 days from II level test to end of diagnostic procedures (p = 0.001), if the diagnostic tests were performed in a hospital with the less volume of activity and higher recall rate (RR) (p < 0.001) and if they had no previous participation to screening tests (p < 0.001). Our results are consistent with previous studies, and encourages the implementation and innovation of the organizational characteristics for breast cancer screening. The success of screening programs requires an efficient indicators monitoring strategy to develop and evaluate continuous improvement processes.


Sign in / Sign up

Export Citation Format

Share Document